The University of South Australia (UniSA) is a leader in medical research and commercialisation, translating scientific discovery into real-world health solutions. Through strategic partnerships and multidisciplinary collaboration, UniSA addresses critical health challenges in areas such as cancer, immunology, neuroscience, and pharmaceutical innovation. The Centre for Cancer Biology—an alliance between UniSA and SA Pathology—is internationally recognised for its groundbreaking work in cancer genetics and personalised medicine. UniSA’s commercialisation pathway, led by UniSA Ventures, supports the transformation of medical research into market-ready technologies, with a strong focus on intellectual property development and translational impact. The University actively seeks licensing opportunities and partnerships to bring its innovations to market, particularly in areas including novel therapeutics, drug delivery systems, diagnostics, and medical devices.